Functional and histopathologic changes in renal transplant patients with new-onset diabetes and dyslipidemia

Transplant Proc. 2011 May;43(4):1254-8. doi: 10.1016/j.transproceed.2011.03.091.

Abstract

Background: The principal risk factors for cardiovascular mortality posttransplantation are hyperglycemia, hypertriglyceridemia, obesity, and smoking.

Methods: Among 115 patients, we assessed the risk factors for new-onset diabetes (NODM) and dyslipidemia (NODL), and their effects on the function and histopathologic changes in the allografts at 1 year posttransplantation.

Results: When evaluating the risk factors and the initial recipient data, we observed a significant difference in age when comparing normal vs NODM patients (P=.004), normal versus NODL patients (P=.002), and normal versus NODL + NODM patients (P=.0001). The difference in body mass index (BMI) was significant when comparing normal with NODM + NODL patients (P=.003). In regard to immunosuppressive therapy, NODM was significantly more frequent among/prescribed tacrolimus (tac; P=.005), whereas subjects who received cyclosporine (CsA) showed a significantly higher incidence of NODL (P=.001). The triglyceride levels were 3.02 ± 1.51 mmol/L among those on CsA versus 2.15 ± 1.57 mmol/L for (P=.004). The difference also proved to be significant for total cholesterol level: 5.43 ± 1.23 mmol/L versus 4.42 ± 1.31 mmol/L respectively (P=.001). In regard to allograft function a significant difference was noted at 1 year after transplantation between the NODM + NODL and the normal group in serum creatinine level (P=.02) as well as the estimated glomerular filtration rate (P=.004). Among diabetic patients, the serum creatinine level measured at posttransplant year 5 was significantly higher than that in 1 year (212.43 vs 147.00 μmol/L; P=.0003). When assessing morphologic changes in the kidney, we observed significantly more frequent interstitial fibrosis/tubular atrophy in all 3 groups compared with normal function patients.

Conclusion: Our clinical study suggested that at 1 year after transplantation allograft function is already impaired in the presence of both medical conditions (NODM and NODL). However, in regard to morphology, a single condition (NODM or NODL) was sufficient to produce histologic changes in the kidney.

MeSH terms

  • Adult
  • Analysis of Variance
  • Atrophy
  • Biomarkers / blood
  • Biopsy
  • Body Mass Index
  • Case-Control Studies
  • Chi-Square Distribution
  • Creatinine / blood
  • Cyclosporine / adverse effects
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / etiology*
  • Dyslipidemias / blood
  • Dyslipidemias / etiology*
  • Female
  • Glomerular Filtration Rate
  • Glycated Hemoglobin / metabolism
  • Graft Survival*
  • Humans
  • Hungary
  • Immunosuppressive Agents / adverse effects
  • Kidney / pathology
  • Kidney / physiopathology
  • Kidney / surgery*
  • Kidney Transplantation / adverse effects*
  • Lipids / blood
  • Logistic Models
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Tacrolimus / adverse effects
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Glycated Hemoglobin A
  • Immunosuppressive Agents
  • Lipids
  • hemoglobin A1c protein, human
  • Cyclosporine
  • Creatinine
  • Tacrolimus